SCHEMBL20909494

SCHEMBL20909494

COCCN(CCOC)c1ccc(C(c2ccc(N(CCOC)CCOC)cc2)c2ccccn2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 7/20 0.50
SLC6A2 P23975 7/20 0.50
SLC6A4 P31645 7/20 0.50
LMNA P02545 3/20 0.47
TSHR P16473 3/20 0.47
ADRA2A P08913 2/20 0.47
CYP2C9 P11712 2/20 0.47
ADRA1A P35348 2/20 0.47
OPRK1 P41145 2/20 0.47
HIF1A Q16665 2/20 0.47
KDM4E B2RXH2 1/20 0.47
ABCB11 O95342 1/20 0.47
ESR1 P03372 1/20 0.47
CYP3A4 P08684 1/20 0.47
PDE4A P27815 1/20 0.47
STAT6 P42226 1/20 0.47
GPR55 Q9Y2T6 1/20 0.47
KCNA5 P22460 4/20 0.44
CHRM2 P08172 7/20 0.42
KCNH2 Q12809 6/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5010074 0.81 SLC6A3 (0.58) SLC6A3SLC6A2SLC6A4LMNATSHR
SCHEMBL20906320 0.80 SLC6A3 (0.43) SLC6A3SLC6A2SLC6A4LMNATSHR
SCHEMBL11185219 0.76 SLC6A3 (0.63) SLC6A3SLC6A2SLC6A4LMNATSHR
SCHEMBL18562084 0.73 KMT2A (0.37) LMNATSHRCYP3A4KCNA5L3MBTL1
SCHEMBL16082898 0.72 EGFR (0.37) ESR1L3MBTL1
SCHEMBL3954915 0.71 MEN1 (0.46) LMNATSHRCYP2C9CYP3A4KCNA5
SCHEMBL20909408 0.70 SMN1; SMN2 (0.47) SLC6A3SLC6A2SLC6A4KDM4ECYP3A4
SCHEMBL15854854 0.70 SLC6A3 (0.70) SLC6A3SLC6A2SLC6A4LMNATSHR
SCHEMBL15854869 0.70 SLC6A3 (0.70) SLC6A3SLC6A2SLC6A4LMNATSHR
SCHEMBL3290275 0.69 SLC6A3 (1.00) SLC6A3SLC6A2SLC6A4LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230250364-A1 LAUNDRY CARE COMPOSITIONS, METHODS, AND TEST KITS FOR DETERMINING AUTHENTICITY PROCTER & GAMBLE (US) 2023-08-10 US disclosed
US-10889717-B2 Compositions, methods, and test kits for determining authenticity MILLIKEN & COMPANY (US) 2021-01-12 US disclosed
US-20190112484-A1 COMPOSITIONS, METHODS, AND TEST KITS FOR DETERMINING AUTHENTICITY MILLIKEN & COMPANY 2019-04-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10889717-B2 Compositions, methods, and test kits for determining authenticity AHR, AR, ARSA SLC6A3 3565/4885SLC6A2 3665/4885SLC6A4 4321/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.